Scancell Holdings (SCLP)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

 13.50p
   
  • Change Today:
      0.000p
  • 52 Week High: 22.75
  • 52 Week Low: 10.63
  • Currency: UK Pounds
  • Shares Issued: 791.92m
  • Volume: 67,200
  • Market Cap: £106.91m

Latest ShareCast News

Scancell developing 'promising' new cancer treatment approach

By Josh White

Date: Thursday 23 Jun 2022

(Sharecast News) - Immunotherapy developer Scancell announced on Thursday that it will develop 'GlyMab' antibodies into T-cell redirecting bispecific (TCB) antibodies, and take them into the clinic as a "promising new therapeutic approach" to treat cancer.

Scancell updates protocol for UK trial in melanoma patients

By Josh White

Date: Wednesday 15 Jun 2022

(Sharecast News) - Immunotherapy developer Scancell updated the market on the phase 2 'SCOPE' clinical trial in melanoma patients on Wednesday, being conducted at multiple centres in the UK.

Scancell opens recruitment for cancer therapy trial

By Josh White

Date: Monday 11 Apr 2022

(Sharecast News) - Immunotherapy developer Scancell announced on Monday that its phase 1 and 2 clinical trial with 'Modi-1' is open for recruitment.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

SCLP Market Data

Currency UK Pounds
Share Price 13.50p
Change Today 0.000p
% Change 0.00 %
52 Week High 22.75
52 Week Low 10.63
Volume 67,200
Shares Issued 791.92m
Market Cap £106.91m

SCLP Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
46.3% below the market average46.3% below the market average46.3% below the market average46.3% below the market average46.3% below the market average
45.45% below the sector average45.45% below the sector average45.45% below the sector average45.45% below the sector average45.45% below the sector average
Price Trend
17.6% below the market average17.6% below the market average17.6% below the market average17.6% below the market average17.6% below the market average
26.98% above the sector average26.98% above the sector average26.98% above the sector average26.98% above the sector average26.98% above the sector average
Income Not Available
Growth Not Available

What The Brokers Say

Strong Buy 2
Buy 0
Neutral 0
Sell 0
Strong Sell 0
Total 2
strong_buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

SCLP Dividends

No dividends found

Trades for 28-Jun-2022

Time Volume / Share Price
12:31 1,432 @ 13.54p
08:49 40,000 @ 13.31p
08:34 7,250 @ 13.60p
08:28 18,518 @ 13.50p

SCLP Key Personnel

CEO Lindy Durrant

Top of Page